Procainamide Hydrochloride

盐酸普鲁卡因胺

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameProcainamide Hydrochloride
Drug Alias Name普鲁卡因胺盐酸盐ProcainamidaProcainamidumProcanbidPronestyl +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsArrhythmias, Cardiac
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesApothecon Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApothecon Llc
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeC01BA02
Related LinksWikipediaDrugBankKEGG